Paper30183752
Generation and selection of pluripotent stem cells for robust differentiation to insulin-secreting cells capable of reversing diabetes in rodents.
Southard SM and 2 others. PLoS One, 2018. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Generation and selection of pluripotent stem cells for robust differentiation to insulin-secreting cells capable of reversing diabetes in rodents. Papers, record 30183752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30183752
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Generation and selection of pluripotent stem cells for robust differentiation to insulin-secreting cells capable of reversing diabetes in rodents.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cellular Reprogramming Techniques | Major topic |
| Diabetes Mellitus, Experimental | Major topic |
| Induced Pluripotent Stem Cells | Major topic |
| Insulin-Secreting Cells | Major topic |
| Adult | |
| Animals | |
| Cell Culture Techniques | |
| Cell Differentiation | |
| Cell Line | |
| Glucose | |
| Humans | |
| Male | |
| Mice | |
| Pancreas |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 31671168 | Correction: Generation and selection of pluripotent stem cells for robust differentiation to insulin-secreting cells capable of reversing diabetes in rodents. | https://conductscience.org/library/papers/31671168 |
Source PubMed
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25018643 | Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges. | Diabetes Metab Syndr Obes | 2014 | https://conductscience.org/library/papers/25018643 | PubMed |
| 2 | 22623968 | A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. | PLoS One | 2012 | https://conductscience.org/library/papers/22623968 | PubMed |
| 3 | 19781928 | How to make beta cells? | Curr Opin Cell Biol | 2009 | https://conductscience.org/library/papers/19781928 | PubMed |
| 4 | 24308533 | Retinoic acid actions through mammalian nuclear receptors. | Chem Rev | 2014 | https://conductscience.org/library/papers/24308533 | PubMed |
| 5 | 18805086 | Retinoic acid synthesis and signaling during early organogenesis. | Cell | 2008 | https://conductscience.org/library/papers/18805086 | PubMed |
| 6 | 28450719 | Advances in islet encapsulation technologies. | Nat Rev Drug Discov | 2017 | https://conductscience.org/library/papers/28450719 | PubMed |
| 7 | 21295703 | Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. | Cell | 2011 | https://conductscience.org/library/papers/21295703 | PubMed |
| 8 | 21726830 | Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. | Cell Stem Cell | 2011 | https://conductscience.org/library/papers/21726830 | PubMed |
| 9 | 18035408 | Induction of pluripotent stem cells from adult human fibroblasts by defined factors. | Cell | 2007 | https://conductscience.org/library/papers/18035408 | PubMed |
| 10 | 1426237 | The thyroid hormone response element is required for activation of the growth hormone gene promoter by nicotinamide analogs. | FEBS Lett | 1992 | https://conductscience.org/library/papers/1426237 | PubMed |
| 11 | 11523032 | The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules. | J Biomed Mater Res | 2001 | https://conductscience.org/library/papers/11523032 | PubMed |
| 12 | 24788136 | Human embryonic stem cell derived islet progenitors mature inside an encapsulation device without evidence of increased biomass or cell escape. | Stem Cell Res | 2014 | https://conductscience.org/library/papers/24788136 | PubMed |
| 13 | 25071868 | A mechanistic role for the chromatin modulator, NAP1L1, in pancreatic neuroendocrine neoplasm proliferation and metastases. | Epigenetics Chromatin | 2014 | https://conductscience.org/library/papers/25071868 | PubMed |
| 14 | 23584186 | A simple tool to improve pluripotent stem cell differentiation. | Nat Methods | 2013 | https://conductscience.org/library/papers/23584186 | PubMed |
| 15 | 24294831 | The role of mouse strain differences in the susceptibility to fibrosis: a systematic review. | Fibrogenesis Tissue Repair | 2013 | https://conductscience.org/library/papers/24294831 | PubMed |
| 16 | 21390058 | The tumorigenicity of human embryonic and induced pluripotent stem cells. | Nat Rev Cancer | 2011 | https://conductscience.org/library/papers/21390058 | PubMed |
| 17 | 22392999 | Wnt/β-catenin signaling promotes differentiation, not self-renewal, of human embryonic stem cells and is repressed by Oct4. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22392999 | PubMed |
| 18 | 26808346 | Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. | Nat Med | 2016 | https://conductscience.org/library/papers/26808346 | PubMed |
| 19 | 22740171 | Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. | Diabetes | 2012 | https://conductscience.org/library/papers/22740171 | PubMed |
| 20 | 22609357 | Crosstalk between TGF-β and hedgehog signaling in cancer. | FEBS Lett | 2012 | https://conductscience.org/library/papers/22609357 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41779359 | Gene Expression at the Pluripotency Stage Predicts Pancreatic Endocrine Differentiation in iPSC Clones. | Stem Cell Rev Rep | 2026 | https://conductscience.org/library/papers/41779359 | PubMed |
| 40116625 | Recent advances in stem cell-based therapies for type 1 diabetes: A glimpse into the future. | Biomol Biomed | 2025 | https://conductscience.org/library/papers/40116625 | PubMed |
| 39918671 | Islet Cell Replacement and Regeneration for Type 1 Diabetes: Current Developments and Future Prospects. | BioDrugs | 2025 | https://conductscience.org/library/papers/39918671 | PubMed |
| 38747221 | Cell Therapies and Gene Therapy for Diabetes: Current Progress. | Curr Diabetes Rev | 2025 | https://conductscience.org/library/papers/38747221 | PubMed |
| 35975353 | Cell delivery systems: Toward the next generation of cell therapies for type 1 diabetes. | J Cell Mol Med | 2022 | https://conductscience.org/library/papers/35975353 | PubMed |
| 35840987 | Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges. | Stem Cell Res Ther | 2022 | https://conductscience.org/library/papers/35840987 | PubMed |
| 34831333 | Application of the Pluripotent Stem Cells and Genomics in Cardiovascular Research-What We Have Learnt and Not Learnt until Now. | Cells | 2021 | https://conductscience.org/library/papers/34831333 | PubMed |
| 32721912 | Stem cell therapy: a potential for the perils of pancreatitis. | Turk J Gastroenterol | 2020 | https://conductscience.org/library/papers/32721912 | PubMed |
| 32641151 | Current progress in stem cell therapy for type 1 diabetes mellitus. | Stem Cell Res Ther | 2020 | https://conductscience.org/library/papers/32641151 | PubMed |
| 32515280 | Genetic Mouse Models and Induced Pluripotent Stem Cells for Studying Tracheal-Esophageal Separation and Esophageal Development. | Stem Cells Dev | 2020 | https://conductscience.org/library/papers/32515280 | PubMed |
| 31671168 | Correction: Generation and selection of pluripotent stem cells for robust differentiation to insulin-secreting cells capable of reversing diabetes in rodents. | PLoS One | 2019 | https://conductscience.org/library/papers/31671168 | PubMed |
| 30820250 | Stem cells as a potential therapy for diabetes mellitus: a call-to-action in Latin America. | Diabetol Metab Syndr | 2019 | https://conductscience.org/library/papers/30820250 | PubMed |
| 30417988 | Concise Review: Lessons Learned from Islet Transplant Clinical Trials in Developing Stem Cell Therapies for Type 1 Diabetes. | Stem Cells Transl Med | 2019 | https://conductscience.org/library/papers/30417988 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30183752
GET https://conductscience.org/api/papers/v1/30183752/references?page=2